Try our Advanced Search for more refined results

Euro Pacific Capital Inc. v. Bohai Pharmaceuticals Group, Inc.,

Track this case

Case Number:

1:15-cv-04410

Court:

New York Southern

Nature of Suit:

Contract: Other

Judge:

Victor Marrero

Firms

  1. March 11, 2016

    Drug Co. May Hide Assets Instead Of Hire Attys, Investor Says

    A Chinese drug company facing a $6 million claim over a botched note offering in New York federal court was given two weeks to find new lawyers on Friday after its efforts to force arbitration failed, despite concerns by an investor that the pharma company would use the time to hide its assets.

  2. February 19, 2016

    Dacheng Parts With Chinese Pharma Client In $6M Suit

    A month after a failed arbitration bid, attorneys with Dacheng Law Offices LLP have asked a New York federal judge for permission to withdraw as counsel for a Chinese herbal pharmaceuticals manufacturer in a $6 million lawsuit over a botched note offering, saying Friday they are no longer authorized to represent the company.

  3. January 22, 2016

    Pharma Co.'s Arbitration Bid Denied In $6M Contract Row

    A Chinese herbal pharmaceuticals manufacturer that has been accused by investors in a $6 million lawsuit of breaching contracts in a $12 million financing offering lost its bid to arbitrate the investors' claims after a federal judge ruled Thursday that the parties had explicitly agreed to resolve all their disputes in New York courts.

  4. December 07, 2015

    Arbitration Required In $6M Breach Suit, Pharma Co. Says

    Chinese herbal pharmaceuticals manufacturer Bohai Pharmaceuticals Group Inc. asked a New York federal judge Friday to force Euro Pacific Capital Inc.'s $6 million breach-of-contract suit into arbitration, saying an arbitration clause in an agreement the investment firm's allegations rely on is binding.

  5. November 17, 2015

    Euro Pacific Fights Bid For Arbitration In $6M Contract Row

    Investment firm Euro Pacific Capital Inc. on Monday moved to derail an herbal pharmaceuticals manufacturer's bid to force Chinese arbitration in a $6 million breach of contract battle, ripping its "misstatements of fact, overactive hyperbole and strained arguments."

  6. June 08, 2015

    Bohai Pharma Hit With Suit Claiming Securities Shenanigans

    Investors led by Westport, Connecticut-based investment firm Euro Pacific Capital Inc. have launched a $6 million lawsuit accusing Chinese herbal pharmaceuticals manufacturer Bohai Pharmaceuticals Group Inc. of breaching contracts and defaulting on an agreement over a $12 million financing offering by "going dark" and leaving investors on the hook.